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The Obstructive Sleep Apnea (OSA) is becoming a significant problem nowadays because it is associated with an 
increasing cardio-metabolic mortality. This disorder is increasing dramatically in the western world because it re-
lated to obesity. The cost-effectiveness ratio of OSA's diagnostic and therapeutic management is a strategic issue 
for health policy, which faces with recent international discussion involving the Western Health Systems. It has 
been shown that costs for simplified models used for diagnosis and outpatient care for OSA are minimal due to 
a more and more reduction of expenditure for both equipment and medical staff. This lack of investments and 
the utilization of portable and simplified monitoring devices could lead to incorrect diagnosis. This short review 
aims to offer discussion topics on the proper diagnosis and treatment of OSA in view of epidemiological / eco-
nomic factors and results in terms of costs and social benefit of the disease. 
 
Keywords: Obstructive Sleep Apnea (OSA); Epworth Sleepiness Scale (ESS),cost-effectiveness (CE); Health 
Technology Assessment (HTA), Affordable Care Act ( ACA); Teleservice (TelaDoc); Home sleep testing 




Laboratory vs portable monitoring for the management 
of OSA 
 
The growing concern that have been manifest-
ing toward Obstructive Sleep Apnea (OSA), es-
pecially in the Western world, has led the focus 
on the more and more clear correlation be-
tween OSA and the reduced quality of life as 
well as the increment of cardiovascular and 
metabolic mortality (Edinger et al. 2016, 237-
247) . The major OSA risk factor is obesity that 
is growing as the incidence of OSA (Romero-
Corral et al. 2010, 711-719). This condition of-
ten is underrecognized in hospitalized obese pa-
tients. A recent study, (Sharma et al. 2015, 717-
723) has showed  to a total of 636 obese  pa-
tients admitted to medical center were classified 
as high risk  Within 4 of discharge,  87% were 
shown to have OSA. The study shows signifi-
cant under-recognition of OSA in obese hospi-
talized patients.  
OSA (Epstein et al. 2009, 263-276) is character-
ized by daytime sleepiness, huabitual snoring 
and at least 5 respiratory-obstructive events per 
hour of sleep, or >15 apneic events per hour in 
absence of symptoms. Other physical character-
istics are highlighted in the pre-clinical test for 
assessing the probability of OSA, that include: 
BMI> 30, neck circumference >43 cm in men 
and 41 in women, daytime hypersomnolence 
measured with a self-assessment questionnaire, 
called the Epworth Sleepiness Scale (ESS) in 
which the cut-off is greater than 10.American 
Academy of Sleep Medicine guidelines suggests 
that portable monitors (nocturnal cardiorespira-
tory monitoring MCRN) may underestimate the 
seriousness of the ipopneic events compared to 
a complete polysomnography - Level 1 - that 
has been performed in a sleep laboratory The 
exponential increment of the OSA incidence, in 
particular in the general population from 40 to 
70 years old, led to an unmet need to simplify 
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the OSA diagnosis using simplified diagnostic 
tests and to improve the treatment. In the past, 
the OSA diagnosis was performed into the 
sleep laboratory situated in the hospital, using 
polysomnography test, which required complex 
equipment and updated medical staff. Pietzsch 
et al. have performed a cost-utility study for the 
diagnosis of OSA. (Pietzsch et al. 2011, 695-
709). This research group have assessed the 
cost-benefit ratio by comparing the three most 
used diagnostic / therapeutic strategies: a) 
overnight PSG along with a manual titration of 
the CPAP working pressure, in the sleep la-
boratory, b) split-night PSG along with manual 
titration of the CPAP working pressure; c) un-
attended portable monitoring (HST) with sub-
sequent treatment with APAP (auto-titrating 
CPAP). 
Another, recent study (Ayas, Pack et Marra 
2011, 691‑692) has considered 191 suspected 
OSA patients tested in advance using a pre-
clinical test. Among them, more than half 
(56.5%) have manifested obstructive sleep ap-
nea. Diagnosis of OSA was missed in 5.8% pa-
tients only, due to the lack of an accurate diag-
nosis from a specialist doctor of a sleep apnea.  
The probability to obtain an accurate diagnosis 
using pre-clinical tests seems not to be influ-
enced by the presence / absence of a specialist 
doctor in accordance with the severity of the 
disease. The authors concluded that OSA could 
be reliably identified using HST test regardless 
of pre-clinical test. 
The increment of the need in diagnostic tools, 
(Aurora et al. 2016, 725-730; Huang et 
Rosenthal 2014, 1376-1379) have led the US to 
organize a home care model, a simplified Home 
Sleep Testing (HST) service company, refunda-
ble by the US insurance agencies, that deals 
with both diagnosis and therapeutic care of 
OSA patients. The services company called (Af-
fordable Care Act) ACA, aims to provide high 
quality healthcare to OSA patients. 
The ACA is gearing up towards a diagnostic 
model that focuses on the doctor-patient rela-
tionship (PCMH). In this home care model, the 
company puts at the center of this relationship 
a network of healthcare services where the pri-
mary cares are subsequently and rapidly inte-
grated after being diagnosed. Basically, once the 
diagnosis and the treatment are determined, the 
Agency rapidly provides a home care technical 
support. This HST model is not inferior to oth-
er diagnostic / therapeutic models. This home 
care diagnosis and treatment is performed by 
health care professionals along with a consulta-
tion with a sleep specialist once. This approach 
reduces the economic costs of the medical staff 
and simplifies the delivery steps in providing 
the therapeutic equipment at home. This model 
results in a diagnostic improvement and in the 
increment of undiagnosed cases of OSA (Antic 




CPAP treatment: clinical and compliance  
 
The treatment with the Continuous Positive 
Airway Pressure (CPAP) devices is the pre-
ferred treatment for severe OSA (Kushida et al. 
2008, 157-171). The CPAP device consists of a 
nasal mask and / or oro-nasal through which 
an airflow is generated at continuous positive 
pressure by a compressed air blower system at 
low pressure. This established controlled pres-
sure is designed to overcome the forces exerted 
by the soft tissues surrounding the upper air-
ways. Because of this, treatment with CPAP is 
referred to as a 'pneumatic splint' (Donovan et 
al. 2015, 1323-1342). 
Same studies have shown the benefits of treat-
ment with CPAP in OSA as a mainstay of the 
treatment of symptoms such as snoring, day-
time sleepiness, improvement of quality of life 
and of sleep as well as secondary depressive 
disorders (Cruz, Drummond et Winck 2012, 
361‑ 66; Donovan et al. 2015, 1323‑ 42). Fur-
thermore, it was shown that the treatment with 
CPAP reduces the risk of cardiovascular com-
plications such as, stroke, heart failure, chronic 
ischemic heart disease and arterial hypertension  
(Barbé et al. 2012, 2161-2168; Gottlieb et al. 
2010, 352-360). 
Unfortunately, this therapy is burdened by a re-
duced compliance by patients that leading them 
to alternative therapies such as the positional 
therapy, surgical, orthodontic, that are able to 
give results superimposable to CPAP and stable 
in time in a well selected patient groups. The 
discovery of clinical phenotypes including 
genotypes with different pathogenic mecha-
nisms has launched a new genetic and biomedi-
cal research field that will lead in the future to 
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nisms has launched a new genetic and biomedi-
cal research field that will lead in the future to 
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new diagnostic and therapeutic strategies in-
creasingly individualized (Malhotra, Orr et 
Owens 2015, 397-403) 
An unmet need in literature is the lack of ad-
herence / compliance to CPAP treatment. It 
should be evaluated, therefore, the possibility to 
develop technical / cultural tools in the form of 
educational / informational interventions able 
to improve adherence to treatment through an 
understanding of OSA and its complications. 
Several studies (Meurice et al. 2007, 37-42) have 
been conducted to assess the effect of educa-
tional / cultural intensive training in OSA and 
CPAP fields. These studies aim to obtain better 
results on the adherence of the patient. Inter-
ventions that have been conducted include the 
verbal-visual instruction by health profession-
als, the applications of the nasal and oral-nasal 
masks as well as the importance of the disease 
and its health effects (Jean Wiese et al. 2005, 
171-174; Golay et al. 2006, 220-227) with 
standardized audiovisual presentations and 
practical demonstrations on performing stand-
ards treatments at home. Up to now, there is 
any "gold standard" training programs in litera-
ture that have steadily improved the adherence 
to CPAP treatment. Many of these clinical trials  
(Wickwire et al. 2013, 680-693) with double 
arm (control and study) have given controver-
sial results. These latter studies were also criti-
cized due to the higher level of education of the 
control arm respect to the study arm, compared 
to a normally routine care. Consequently, re-
sults on the adherence in the study arm has ap-
peared worse. However, the majority of the ex-
perts still recommend to all patients that start 
CPAP, a high level of intensive instruction. 
 
 
Health-care providers and CPAP: cost-effectiveness of 
models of care 
 
The Health Technology Assessment is a multi-
dimensional and multidisciplinary approach for 
the analysis of clinical, social, organizational, 
economic and legal implications in Italy. This 
approach undergoes a multi-dimensional evalu-
ation such as the efficacy, safety, cost, and the 
social and organizational impact (Velardi et al. 
2011). 
Telemedicine interventions (IT) is a remote 
communication system of IT / medical data 
that is used to save time and reduce all the costs 
spent for managing a home care service for 
chronic diseases (Toma et al. 2014, 200-211; 
Park et al. 2014, 65-72). Not surprisingly, a 
number of clinical studies have been conducted 
to evaluate the effectiveness of telemedicine in-
terventions (IT) on adherence to CPAP treat-
ment. An expert IT technician has, in fact, pro-
duced some interesting data on health proce-
dures on CPAP (Fox et al. 2012, 477-481). 
The IT reports were transmitted and received 
from the individual CPAP home units onto the 
reference Provider center wirelessly therefore 
data from the study were collected and pro-
cessed. Recorded data were represented by: a) 
loss of pressure in the mask, b) residual AHI c) 
number of hours of use (5 hours per night). Er-
rors in performing the treatment were easily de-
tected from the technician, who was able to call 
the patients the next morning through the cen-
tral Provider and solve any problems about the 
low efficiency of the treatment. Result were 
seen after three months: the group assigned to 
the intervention in telemedicine had 1.88 hours 
/ night of CPAP more compared to the control 
group with a lower residual AHI. 
Another Spanish clinical multicenter random-
ized controlled trial (Isetta et al. 2015, 1054-
1061) used telemedicine for studying economic 
and clinical impacts as well the improvement of 
the quality of life (QoL) with CPAP treatment 
compared to traditional follow-up with face-to-
face doctor-patient controls. 139 patients were 
enrolled with sufficient knowledge of IT world. 
The follow-up included 3 controls at 1, 3 and 6 
months to assess the quality of sleep, the side 
effects of treatment with CPAP and QoL. In 
this study were also detected the costs of the 
treatment and management from the beginning 
to the end of the study. 
Results of the study were that a strategy based 
on telemedicine for follow-up of CPAP treat-
ment in patients with severe OSAS, was as ef-
fective as a therapy performed in hospital in ac-
cordance with the gold standard, in terms of 
the compliance with CPAP and the improve-
ment of the symptoms, with comparable side 
effects and satisfaction rates. The strategy based 
on telemedicine had a reduction of total costs 
in the transport service and productivity. 
These new IT telemonitoring systems permit to 
save operating costs and manage several pa-
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tients simultaneously (at least a hundred) using 
a single provider. However, they hint at possi-
ble medico-legal disputes. We try to address 
them. The first aspect to be defined is the fact 
that there is no standard of care for telemedi-
cine at international level. Standards of care ex-
ist just for services for the individual but there 
are still not any e-Health practices. Medico-legal 
issues are: a) respect for personal privacy, b) in-
accuracies of self-reporting of patients in data 
recording, c) the resolution limits of data to be 
recorded and the consequent delays due to fail-
ure / delayed treatment after the recording of 
data, d) failure of the systems that do not work 
correctly. In the US, there is a national society 
in telemedicine named TelaDoc (Gallegos 
2015) which features a American National 
Committee to guarantee certification of elec-
tronic systems used in telemedicine, along with 
the production of evidence-based clinical prac-
tice guideline of registered data quality. 
Another English multicenter randomized con-
trolled study (McMillan et al. 2015, 1-188) as-
sessed the clinical and economic aspects of the 
CPAP treatment in OSA elderly patients 
(PREDICT study). The study have showed that 
CPAP treatment in these patients (> 65 years) 
reduced the subjective and objective sleepiness 
similarly compared to younger patients. Sec-
ondary goals were determine the CPAP clinical 
efficacy, the cost-effectiveness ratio and the real 
usefulness of the treatment (model-based cost-
effectiveness analysis) compared to alternative 
treatments with APAP / Bilevel / C FLEX 
(BSC).The QoL at 12 months of treatment was 
measured by the European Quality of Life-5 
Dimensions (EQ-5D); 
In elderly patients with OSA, CPAP treatment 
reduced the somnolence more significantly 
compared to treatment with APAP / Bi-Level / 
C FLEX (BSC) over a period of 12 months, 
improving the EQ-5D.In this recent clinical 
study (Tan et al. 2015, 525-535) approximately 
50% of patients with OSA were intolerant to 
CPAP, this resulted in the selection of other 
therapeutic modalities such as surgical treat-
ment. In order to evaluate the cost-
effectiveness ratio in intolerant patients, this re-
search group have compared three treatment 
strategies: (a) no treatment, (b) only CPAP and 
(c) CPAP followed by surgery (reconstructive 
palate-pharyngeal surgery (PPRS) or multilevel 
surgery (MLS]). Obtained results showed that 
CPAP therapy followed by PPRS (CPAP-
PPRS) was the most profitable treatment com-
pared to treatment with single CPAP and com-
pared to the other strategies. 
Another interesting prospective randomized 
controlled trial, published in 2010 by an Italian 
research group (Vicini et al. 2010, 14-20), have 
compared the efficacy of the ORL surgery, the 
maxilla-mandibular advancement (MMA) ver-
sus positive ventilation (auto-titrating) APAP. 
In conclusion, the study has shown that MMA 
can be a valid alternative therapeutic tool, not 





In conclusion, there are many clinical studies 
that compared the efficacy between the diag-
nostic / ambulatory treatment versus diagnostic 
/ hospital treatment. All these reports have elu-
cidated that the management strategies for OSA 
are not clinically inferior to the hospital treat-
ment and can produce similar results compared 
to the diagnostic / laboratory sleep treatment in 
hospital (Chai-Coetzer, Antic et McEvoy 2013, 
605-615). However, we must point out some 
important limitations about HST when used in 
a long-term management strategy, because it 
can produce: a) limited capacity to diagnose 
sleep disorders other than OSA or non OSA 
syndrome related to metabolic disorders, neuro-
logical; b) the need to review / reevaluate the 
raw data that come automatically without per-
forming a manual analysis of the nocturnal 
polygraphic tracings; c) uncertainties about the 
long-term use of this outpatient strategy on re-
gards to the overall cost-effectiveness results 
compared to the hospital diagnostic plan that is 
based on the supervised polysomnography at 
1st level. 
There are also new emerging results in the liter-
ature that support the role of non-medical 
health professionals expert in sleep study such 
as nurses, care giver, IT / health care, who are 
able to manage the home care OSA in a  cost-
effective way. We still need of more long-term 
prospective studies that can evaluate the cost-
effectiveness ratio, including direct and indirect 
costs of hospital management models versus 
models that take into account new qualified 
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important limitations about HST when used in 
a long-term management strategy, because it 
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non-medical personnel care. Finally, future 
knowledge in this area will come from the 
application of new technologies. Olivia J.et al 
(Walch, Cochran et Forger 2016, e1501705) to 
have shown that the sleep wake rhythm is 
changed from a social plan. They used 
smartphone app that  have developed, EN-
TRAIN, accurately collects data on sleep habits 
around the world. This work better defines and 
personalizes “normal” sleep, produces hypothe-
ses for future testing in the laboratory, and sug-
gests important ways to counteract the global 
sleep crisis Moreover, we use mobile technolo-
gy to collect a massive data set at essentially no 
cost. In analyzing these large data sets, mathe-
matical modeling will be key to generating use-
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